Thanks, Daniel. I'll cover sales and marketing and CapEx. Our sales and marketing includes four main for us. First, distributor and direct customer support. Second, newsletters and videos. Third, evaluation boards. And finally, trade shows. Distributor and customer support involves customer visits, answering questions, and providing fast, well-informed application engineering. We increased the frequency of newsletters and videos in the past quarter and we have good open rates and click through metrics. Evaluation boards support more efficient customer product evaluations and in the past quarter, we introduced dozens of new evaluation boards. We exhibited at two major trade shows last month, including SENSOR+TEST, which is billed as the leading international trade fair for sensor, measuring and testing technology. That show was in Nuremberg, Germany. We've typically relied on distributors to represent us at international trade shows. We continue to co-exhibit with a German distributor, but this year, we also had our own booth, which gave us more space to promote our products. We were also at Sensors Converge in Silicon Valley, which is billed as North America's largest electronics event. We gained some high-quality leads and there was particular interest in tunneling magnetoresistance sensors. We believe the investments and shows will pay off in future sales. Last quarter, we discussed our plans for $4 million to $5 million in capital investments over the next two fiscal years, fiscal 2025 and 2026. The investments will increase our capacity and capabilities, including the capability to manufacture wafer-level chip scale packages in-house. These parts will be smaller, higher performance and allow us to be more self-sufficient and capture more value. Most of our products are currently packaged in Asia by Outsourced Semiconductor Assembly and Test or OSAT, subcontractors using conventional plastic overmolding. Wafer-level chip scale parts can be even smaller than these encapsulated components. We have provided customers with wafer-level chip scale prototypes and there has been solid customer interest. We hope to begin some production late this fiscal year. Our $917,000 CapEx in the past quarter was mostly a down payment for custom, purpose-built production equipment to be delivered next year. In the past quarter, the State of Minnesota announced we had been awarded incentives from the Minnesota Investment Fund. There's up to $111,000 of potential incentives to be paid in 2026 based on the number of jobs added and certain other conditions. We were also awarded a $200,000 seven-year no-interest loan intended to help finance new production equipment. The funding is subject to agreements that have not been finalized yet. Our Annual Shareholders' Meeting will be August 1st. Our meetings have been in-person, except during the pandemic, so shareholders can meet our managers and directors and see hands-on product demonstrations. In response to shareholders' request, this year's meeting will be here at NVE with tours, so shareholders can see what we do. Our annual meetings follow themes, and this year, the theme will be the Olympics, which will be going on at that time. We'll have live product demonstrations showing the precision, strength and endurance of our products. If you can't attend, you can see product demonstrations on our website or YouTube channel. Our proxy statement for the meeting is available via our website or the SEC's website. There are three agenda items for the annual meeting. The first agenda item is Election of Directors. Sadly, Rich Kramp who had been a Director for nearly 10 years passed away in May. Rich has been a valuable member of our Board and was dedicated to our company and our shareholders. We miss him. We were pleased to welcome Dr. Kelly Wei to our Board to fill Rich's unexpired term. She's also nominated for a full term starting at the annual meeting. Kelly is a Medtronic executive and an accomplished engineer. Her strong management, technical and medical device experience and her engineering and medical education make her exceptionally qualified to serve as a director. The second agenda item is approval of officer compensation. Our compensation principles as detailed in our proxy include, we don't overpay our officers. Our officers have the same fringe benefits as all employees and there are no executive perks or golden parachutes. The third agenda item is the ratification of our auditors for this fiscal year, the year ending March 31st, 2025. Boulay has been our auditor since 2019, and we recommend their approval for our next audit. We expect representatives from Boulay to attend the annual meeting. The proxy reports total shareholder return for the past three fiscal years was 46%, which far exceeded the broad markets. Returns consisted of 29% stock appreciation and 17% from dividends. Now we'd like to open the call for questions.